Electromed Inc. logo

Electromed Inc. (ELMD)

Market Open
8 Dec, 15:20
AMEX AMEX
$
28. 14
+0.34
+1.2%
$
221.2M Market Cap
32 P/E Ratio
0% Div Yield
5,738 Volume
0.47 Eps
$ 27.81
Previous Close
Day Range
27.95 28.32
Year Range
17.73 35.56
Want to track ELMD and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 63 days

Summary

ELMD trading today higher at $28.14, an increase of 1.2% from yesterday's close, completing a monthly increase of 5.93% or $1.57. Over the past 12 months, ELMD stock lost -5.59%.
ELMD is not paying dividends to its shareholders.
The last earnings report, released on Nov 12, 2025, missed the consensus estimates by -0.22%. On average, the company has fell short of earnings expectations by -0.06%, based on the last three reports. The next scheduled earnings report is due on Feb 09, 2026.
The stock of the company had never split.
The company's stock is traded on 1 different exchanges and in various currencies, with the primary listing on AMEX (USD).

ELMD Chart

Similar

Armata Pharmaceuticals Inc.
$ 5.64
+0.18%
Senseonics Holdings, Inc.
$ 6.72
+1.51%
Perspective Therapeutics Inc.
$ 2.34
-2.5%
PLX
Protalix Biotherapeutics Inc.
$ 1.72
-0.87%
Cybin Inc.
$ 5.97
-0.25%
3 Reasons Why Growth Investors Shouldn't Overlook Electromed (ELMD)

3 Reasons Why Growth Investors Shouldn't Overlook Electromed (ELMD)

Electromed (ELMD) possesses solid growth attributes, which could help it handily outperform the market.

Zacks | 6 days ago
Wall Street Analysts See a 36.98% Upside in Electromed (ELMD): Can the Stock Really Move This High?

Wall Street Analysts See a 36.98% Upside in Electromed (ELMD): Can the Stock Really Move This High?

The consensus price target hints at a 37% upside potential for Electromed (ELMD). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Zacks | 6 days ago
Best Momentum Stock to Buy for Nov. 17th

Best Momentum Stock to Buy for Nov. 17th

ROKU, NRIM and ELMD made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on November 17, 2025.

Zacks | 2 weeks ago

Electromed Inc. (ELMD) FAQ

What is the stock price today?

The current price is $28.14.

On which exchange is it traded?

Electromed Inc. is listed on AMEX.

What is its stock symbol?

The ticker symbol is ELMD.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0%.

What is its market cap?

As of today, the market cap is 221.2M.

When is the next earnings date?

The next earnings report will release on Feb 09, 2026.

Has Electromed Inc. ever had a stock split?

No, there has never been a stock split.

Electromed Inc. Profile

Health Care Equipment & Supplies Industry
Healthcare Sector
James L. Cunniff CEO
AMEX Exchange
285409108 CUSIP
US Country
174 Employees
- Last Dividend
- Last Split
13 Aug 2010 IPO Date

Overview

Electromed, Inc. is a pioneering company focusing on the advancement, manufacturing, marketing, and sales of airway clearance therapy alongside related products leveraging high frequency chest wall oscillation (HFCWO) therapy. This innovative approach is pivotal in pulmonary care for patients across various age groups both within the United States and internationally. With a foundation laid in 1992 and headquartered in New Prague, Minnesota, Electromed, Inc. is dedicated to enhancing the quality of life for individuals suffering from compromised pulmonary function due to conditions such as bronchiectasis, cystic fibrosis, and neuromuscular diseases. The company primarily serves the home health care and institutional markets, reaching its customers through physicians, health care providers, and direct patient sales.

Products and Services

  • SmartVest Airway Clearance System
  • This is a flagship product designed by Electromed, Inc., providing an effective airway clearance therapy through the application of high frequency chest wall oscillation. The system is engineered for ease of use and comfort, addressing the needs of patients with compromised pulmonary functions.

  • SmartVest SQL System
  • This system encompasses an inflatable therapy garment, a programmable air pulse generator, and a patented single hose. This hose functions to deliver air pulses from the generator to the garment, facilitating effective delivery of airway clearance therapy to the patient.

  • SmartVest Connect
  • Integrating wireless technology, SmartVest Connect offers a personalized HFCWO therapy management portal. This innovation supports improved monitoring and management of therapy, empowering patients with chronic pulmonary conditions to engage more actively in their treatment plans.

  • Single Patient Use SmartVest and SmartVest Wrap
  • Specifically designed for the acute care setting, these products cater to health care providers offering a solution for effective airway clearance on a single-patient basis. They are intended to meet the urgent needs of patients in healthcare facilities.

Contact Information

Address: 500 Sixth Avenue NW
Phone: 952 758 9299